Yasuhiro Funahashi
8PUBLICATIONS
56CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (8)
Sort by Publication Date:
|Apr 14, 2026
Leveraging Network-Based Transcriptome Analysis from Mouse Tumor Models and Explainable Artificial Intelligence to Advance the Understanding of the Antitumor Activity of Lenvatinib.Haruna Imamura, Sufeng Chiang, Megumi Kuronishi
|Jul 10, 2024
Inhibition of Notch4 Using Novel Neutralizing Antibodies Reduces Tumor Growth in Murine Cancer Models by Targeting the Tumor Endothelium.Jason W-L Eng, Yu Kato, Yusuke Adachi
|Oct 10, 2023
Amelioration of Tumor-promoting Microenvironment via Vascular Remodeling and CAF Suppression Using E7130: Biomarker Analysis by Multimodal Imaging Modalities.Ken Ito, Masayuki Yamaguchi, Taro Semba
|Jan 25, 2023
Liposome-Encapsulated Eribulin Shows Enhanced Antitumor Activity over Eribulin for Combination Therapy with Anti-PD-1 Antibody.Yuki Niwa, Keito Adachi, Kimiyo Tabata
|Nov 10, 2021
Inhibition of FGFR Reactivates IFNγ Signaling in Tumor Cells to Enhance the Combined Antitumor Activity of Lenvatinib with Anti-PD-1 Antibodies.Yusuke Adachi, Hiroshi Kamiyama, Kenji Ichikawa
|Jun 10, 2021
Pharmacodynamic Biomarkers Predictive of Survival Benefit with Lenvatinib in Unresectable Hepatocellular Carcinoma: From the Phase III REFLECT Study.Richard S Finn, Masatoshi Kudo, Ann-Lii Cheng
Pageof 2
Frequent Collaborators
3 joint publications
Yu Kato
2 joint publications
Takanori Abe
2 joint publications
Taro Semba
2 joint publications
Yukinori Minoshima
2 joint publications
Ken Ito
2 joint publications
Yoichi Ozawa
2 joint publications
Kimiyo Tabata
1 joint publications
Cristina Valero
1 joint publications
Ritesh Kotecha
1 joint publications
Martin H Voss
